The situation on antimicrobial agents and chemotherapy in 2002: Highlights of the 42nd ICAAC

Bibliography

• WOOLHOUSE M: Population biology of emerging and re-emerging pathogens. Trends Microbial (2002) 10\(Suppl. 10):S3–S7.
   Google Scholar
• JERNIGAN DB, RAGHUNATHAN PL, BELL BP et al: Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Enterg. Infect. Dis. (2002) 8(10):1019–1028.
   PubMed Web of Science ®Google Scholar
• MOUREZ M, LACY DB, CUNNINGHAM K et al: 2001: a year of major advances in anthrax toxin research. Trends Microbial. (2002) 10(6):287–293.
   PubMedGoogle Scholar
• ••Recent advances in anthrax biology.
   Google Scholar
• KAISER J: 2003 budget: bioterrorism drives record NIH request. Science (2002) 295(5556):785.
   PubMedGoogle Scholar
• KAISER J: NIH Director-Designate. Money, mission, management top Zerhounfs agenda. Science (2002) 296(5565):24–25.
   PubMedGoogle Scholar
• FELMINGHAM D: Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective resistant organism tracking andepidemiology for the ketolide telithromycin.Infect. (2002) 44(Suppl.):A3–A10.
   Google Scholar
• SMITH DL, HARRIS AD, JOHNSON JA, SILBERGELD EK, MORRIS JG Jr: Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc. Natl. Acad. Sci. USA (2002) 99(9):6434–6439.
   PubMed Web of Science ®Google Scholar
• LIM D, STRYNADKA NC: Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Nat. Struct. Biol. (2002) 9(11):870–876.
   PubMedGoogle Scholar
• NOBLE WC, VIRANI Z, CREE RG: Co-transfer of vancomycin and other resistance genes from Enterocaccus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbial. Lett. (1992) 72(2):195–198.
   PubMedGoogle Scholar
• NO AUTHORS LISTED: Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Marb. Mortal. Wkly Rep. (2002) 51(26):565–567.
   PubMedGoogle Scholar
• TRIEU-CUOT P, GERBAUD G, LAMBERT T, COURVALIN P: In vivo transfer of genetic information between Gram-positive and Gram-negative bacteria. EMBO J (1985) 4(13A):3583–3587.
   Google Scholar
• ••An excellent reference showing horizontaltransfer between distant bacteria.
   Google Scholar
• MCKEEGAN K, BORGES-WALMSLEY M, WALMSLEY A: Microbial and viral drug resistance mechanisms. Trends Microbial (2002) 10\(Suppl. 10):58–514.
   PubMedGoogle Scholar
• GREEN DW: The bacterial cell wall as a source of antibacterial targets. Expert Opin. Ther. Targets (2002) 6(1):1–19.
   PubMedGoogle Scholar
• FERBER D: Infectious disease. New weapons in the battle of the bugs. Science (2002) 295(5554):433–434.
   PubMedGoogle Scholar
• GIGLIONE C, PIERRE M, MEINNEL T: Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents. Mal Microbial (2000) 36(6):1197–1205.
   PubMedGoogle Scholar
• ••A recent review of PDF and its use as atarget for antimicrobial drugs.
   Google Scholar
• YUAN Z, TRIAS J, WHITE RJ: Deformylase as a novel antibacterial target. Drug Discov. Today (2001) 6(18):954–961.
   PubMed Web of Science ®Google Scholar
• GIGLIONE C, MEINNEL T: Resistance to anti-peptide deformylase drugs. Expert Opin. Ther. Targets (2001) 5(3):415–418.
   PubMedGoogle Scholar
• BUSH K, JACOBY GA, MEDEIROS AA: A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antlinicrob. Agents Cheinother. (1995) 39(6):1211–1233.
   PubMed Web of Science ®Google Scholar
• PAYNE DJ, DU W, BATESON JH: beta-lactamase epidemiology and the utility ofestablished and novel beta-lactamase inhibitors. Expert Opin. Investig. Drugs\(2000) 9(2):247–261.
   Google Scholar
• HILGERS MT, LUDWIG ML: Crystal structure of the quorum-sensing protein LuxS reveals a catalytic metal site. Proc. Nati Acad. Sci. USA (2001) 98(20):11169–11174.
   PubMedGoogle Scholar
• WILLIAMS P: Quorum sensing: an emerging target for antibacterial chemotherapy? Expert Opin. Ther. Targets, (2002) 6(3):257–274.
   PubMedGoogle Scholar
• PENNISI E: Malaria research. Parasite genome sequenced, scrutinized. Science (2002) 298(5591):33–34.
   PubMedGoogle Scholar
• GIGLIONE C, MEINNEL T: Peptide deformylase as an emerging target for antiparasitic agents. Enterg. Ther. Targets (2001) 5(1):41–57.
   PubMedGoogle Scholar
• SACHS JD: A new global effort to control malaria. Science (2002) 298(5591):122–124.
   PubMedGoogle Scholar
• PARKINSON T: The impact of genomics on anti-infectives drug discovery and development. Trends Nlicrobiol. (2002) 10\(Suppl. 10):522–526.
   Google Scholar
• HANEY SA, ALKSNE LE,DUNMAN PM, MURPHY E,PROJAN SJ: Genomics in anti-infective drug discovery getting to endgame. Curr. Phann. Des. (2002) 8(13):1099–1118.
   PubMedGoogle Scholar
• SCHMID M: Structural proteomics: the potential of high-throughput structure determination. Trends Microbial. (2002) 10\(Suppl. 10):527–531.
   Google Scholar
• GUILLOTEAU JP, MATHIEU M, GIGLIONE C et al.: The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents. _J. MoL (2002) 320(5):951–962.
   Google Scholar
• hilp://www.icaac.org The official website of the ICAAC.
   Google Scholar
• http://www.sound-solution.com The website to access to purchase a CD-ROM containing audiotapes of the majority of the ICAAC sessions of the 42nd ICAAC in .mp3 format ($200).
   Google Scholar
• hilp://www.britbio.co.uldicaac2002.htm The website to access to obtain a free electronic version of the posters presented by British-Biotech at the ICAAC in .pdf format.
   Google Scholar